Delivery Order SPE2DB20D7059-SPE2DB26FGRV6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,569.12 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 6, 2025, with completion targeted for August 7, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,594.26 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) with a ceiling value of $1,074.73 under firm fixed pricing. This award, issued on November 3, 2025, represents a non-competitive set-aside delivery order with an ultimate completion date of November 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the point of performance for this pharmaceutical supply contract. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,780.32 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $5,151.50 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5 mL units. This non-competed, firm fixed-price delivery order was awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ml) under a firm fixed-price contract with a ceiling value of $1,900.20. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive delivery order without set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,574.71 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ciprofloxacin-dexamethasone otic suspension (7.5ML) with a ceiling value of $1,569.12 under a firm fixed-price contract. The award was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive award. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,183.28 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on September 24, 2025, with completion targeted for September 25, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, supports federal medical procurement needs through AmerisourceBergen's pharmaceutical distribution capabilities. The contract is performed at the vendor's corporate office...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB26FGRV6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone otic suspension (7.5ml) valued at $5,275.58 under a firm fixed-price contract. The award, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This contract serves the Defense Logistics Agency's medical supply chain operations supporting military and federal healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, demonstrating AmerisourceBergen Drug Corp's role as a critical pharmaceutical vendor within the federal medical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 11/3/25 |